Patent details

Basic Information

Publication number:

EP2257311

PCT Application Number:

PCT/US/2009/035339

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP097142863

PCT Publication Number:

WO/2009/108806

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CONJUGATED FACTOR VIII MOLECULES

French Title of Invention:

MOLÉCULES DE FACTEUR VIII CONJUGUÉES

German Title of Invention:

KONJUGIERTE FAKTOR-VIII-MOLEKÜLE

SPC Number:

Dates

Filing date:

26/02/2009

Grant date:

16/04/2014

EP Publication Date:

16/04/2014

PCT Publication Date:

03/09/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/12/2010

EP B1 Publication Date:

16/04/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

26/02/2015

Expiration date:

26/02/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

26/02/2009

 

 

Name:

Novo Nordisk A/S

Address:

Novo Allé, 2880 Bagsværd, Denmark (DK)

Inventor

1

Name:

THIM Lars

Address:

Denmark (DK)

2

Name:

BOLT Gert

Address:

Denmark (DK)

3

Name:

VANDAHL Brian, Berg, Stidsen

Address:

Denmark (DK)

4

Name:

DEFREES Shawn

Address:

United States (US)

5

Name:

STENNICKE Henning, Ralf

Address:

Denmark (DK)

6

Name:

STEENSTRUP Thomas, Dock

Address:

Denmark (DK)

Priority

1

Priority Number:

32006

Priority Date:

27/02/2008

Priority Country:

United States (US)

2

Priority Number:

43354

Priority Date:

08/04/2008

Priority Country:

United States (US)

3

Priority Number:

58869

Priority Date:

04/06/2008

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 47/48;

Filing date	Document type	Number of pages